Custom SNP Assay Design and Validation

The contract involves the design and validation of custom TaqMan SNP genotyping assays targeting ten specific mitochondrial DNA single nucleotide polymorphisms, requiring precise bioinformatics analysis to ensure primer specificity and avoid cross-reactivity with non-target sequences. The scope includes developing assay components optimized for quantitative PCR, followed by experimental validation to confirm robustness, sensitivity, and accuracy under standardized conditions. All work must adhere to stringent technical benchmarks to ensure reliable genotyping results suitable for downstream research applications in mitochondrial genetics. The effort is structured as a subcontract under the National Institutes of Health, part of the Department of Health and Human Services, with a NAICS code of 541715 indicating it falls under research and development in the physical, engineering, and life sciences. The solicitation was posted on July 29, 2026, with responses due by August 7, 2026, and the performance location is unspecified. While no set-aside provisions or point of contact details are provided, the focus remains entirely on delivering technically validated SNP assays with supporting bioinformatics documentation to meet the funding agency’s research needs.